MyHep All 28 Tablet


tablets per bottle: 28; Manufacturer: Mylan Pharmaceuticals Pvt Ltd


Buy one course (3 bottles) get free shipping
Composition Sofosbuvir 400mg and Velpatasvir 100mg (EPCLUSA)
Substitutes Epclusa 28s, Hepcvel 28s, Panovir 28s, Sofosvel 6s, Sovihep V 28s, VelaKast 28s, VelaSof 28s, Velpaclear 28s, Virvel 28s, Velpanat 28s
Primary Use Chronic hepatitis C virus (HCV) infection

Medicine Overview of MyHep All Tablet


Uses of MyHep All Tablet

MyHep All Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.

MyHep All Tablet side effects


Headache, Tiredness.

How to use MyHep All Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. MyHep All Tablet may be taken with or without food, but it is better to take it at a fixed time.

How MyHep All Tablet works

MyHep All Tablet is a combination of two antiviral medicines: Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.

MyHep All Tablet related warnings

Special precautions for MyHep All Tablet

Interaction with alcohol is unknown. Please consult your doctor.
MyHep All Tablet is probably safe to use during pregnancy. Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
MyHep All Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Do not drive unless you are feeling well. MyHep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
MyHep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of MyHep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of MyHep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
MyHep All Tablet is safe to use in patients with liver disease. No dose adjustment of MyHep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine.

Additional information

Weight 0.067 kg
Dimensions 5 × 5 × 9.7 cm